18511605

Source:http://linkedlifedata.com/resource/pubmed/id/18511605

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007226, umls-concept:C0019004, umls-concept:C0030705, umls-concept:C0051696, umls-concept:C0441471, umls-concept:C0857121, umls-concept:C1280500, umls-concept:C1524112
pubmed:issue	11
pubmed:dateCreated	2008-10-16
pubmed:abstractText	Hypertensive haemodialysis patients may be at a high risk for cardiovascular events. This study was undertaken to ascertain whether the calcium channel blocker amlodipine reduces mortality and cardiovascular events in these high-risk patients.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-11130523, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-11239016, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-12028456, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-12401125, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-12897077, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-15207952, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-15207957, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-15699452, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-16034009, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-16154016, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-16421161, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-16632557, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-16997057, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-17063175, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-17276798, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-17717562, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-7872317, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-8731103, http://linkedlifedata.com/resource/pubmed/commentcorrection/18511605-9531176
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8706402
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Amlodipine, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1460-2385
pubmed:author	pubmed-author:HopfenmuellerWernerW, pubmed-author:MaierAlexandraA, pubmed-author:ScholzeAlexandraA, pubmed-author:TepelMartinM, pubmed-author:ZidekWalterW
pubmed:issnType	Electronic
pubmed:volume	23
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3605-12
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:18511605-Aged, pubmed-meshheading:18511605-Amlodipine, pubmed-meshheading:18511605-Blood Pressure, pubmed-meshheading:18511605-Calcium Channel Blockers, pubmed-meshheading:18511605-Cardiovascular Diseases, pubmed-meshheading:18511605-Chronic Disease, pubmed-meshheading:18511605-Double-Blind Method, pubmed-meshheading:18511605-Endpoint Determination, pubmed-meshheading:18511605-Female, pubmed-meshheading:18511605-Germany, pubmed-meshheading:18511605-Humans, pubmed-meshheading:18511605-Hypertension, pubmed-meshheading:18511605-Kidney Diseases, pubmed-meshheading:18511605-Male, pubmed-meshheading:18511605-Middle Aged, pubmed-meshheading:18511605-Prospective Studies, pubmed-meshheading:18511605-Renal Dialysis, pubmed-meshheading:18511605-Risk Factors
pubmed:year	2008
pubmed:articleTitle	Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients.
pubmed:affiliation	Medizinische Klinik Nephrologie, Charité Campus Benjamin Franklin, Berlin, Germany. martin.tepel@charite.de
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Multicenter Study